---
title: "Token Sciences released its first-quarter performance, with a net profit attributable to the parent company of 79.7025 million yuan, an increase of 61.09%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237577468.md"
description: "Token Sciences released its Q1 2025 performance, with operating revenue of 2.793 billion yuan, a year-on-year increase of 7.31%; net profit attributable to the parent company was 79.7025 million yuan, a year-on-year increase of 61.09%; net profit excluding non-recurring gains and losses was 74.1872 million yuan, a year-on-year increase of 112.77%; basic earnings per share were 0.0324 yuan"
datetime: "2025-04-25T12:31:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237577468.md)
  - [en](https://longbridge.com/en/news/237577468.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237577468.md)
generator: "portal-rs"
---

# Token Sciences released its first-quarter performance, with a net profit attributable to the parent company of 79.7025 million yuan, an increase of 61.09%

According to the Zhitong Finance APP, Token Sciences (300088.SZ) released its first-quarter report for 2025, showing an operating income of 2.793 billion yuan, a year-on-year increase of 7.31%. The net profit attributable to shareholders of the listed company was 79.7025 million yuan, a year-on-year increase of 61.09%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 74.1872 million yuan, a year-on-year increase of 112.77%. The basic earnings per share were 0.0324 yuan

### Related Stocks

- [300088.CN](https://longbridge.com/en/quote/300088.CN.md)

## Related News & Research

- [Zaptec insider-linked company buys shares worth NOK 12.36 million](https://longbridge.com/en/news/296378460.md)
- [MODU: Triple-digit PPT growth and improved EBITDA margin despite revenue decline; phase III trial recruitment completed](https://longbridge.com/en/news/296601269.md)
- [VIMAB: Strong Q2 revenue growth and new battery contracts signal improving performance](https://longbridge.com/en/news/296577862.md)
- [Callosum raises USD 100 million seed round led by Atomico](https://longbridge.com/en/news/296446845.md)
- [DIMRI: H1 2026 net profit rose to ₪495.6M on revenue of ₪780.5M, with robust liquidity and equity](https://longbridge.com/en/news/296448412.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**